Amarin Corp Plc (AMRN)

[couldbebetter]

What I find so disheartening about AMRN, is past management teams
never seemed to pursue the use of Vascepa as an adjunct drug for
various cancer treatments, such as Merck's Keytrda cancer drug that has
been used in "thousands" of trials. As I've harped on this same issue many
other times, it seems to me that the "new formulation" may have great value
if a BP would acquire AMRN and do the studies needed to get it launched as
an adjunct drug for other cancer drugs and treatments. What is horrible is
if this isn't done (proven or disproven,) then a potentially very SAFE, economic,
and effective drug to that may provide far better outcomes to patients than
not having this drug. (Just my one rant for the day...I haven't had one in a while.)